Pathstone Family Office’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$288K Buy
4,374
+2,076
+90% +$155K ﹤0.01% 1337
2023
Q2
$203K Buy
+2,298
New +$164K ﹤0.01% 1142
2023
Q1
Sell
-6,023
Closed -$294K 1490
2022
Q4
$294K Buy
6,023
+662
+12% +$30.6K ﹤0.01% 1252
2022
Q3
$277K Buy
+5,361
New +$318K ﹤0.01% 1246
2022
Q2
Sell
-3,629
Closed -$376K 1136
2022
Q1
$376K Buy
3,629
+100
+3% +$8.21K 0.01% 662
2021
Q4
$288K Hold
3,529
0.01% 724
2021
Q3
$234K Buy
+3,529
New +$250K 0.01% 761
2014
Q4
Sell
-694
Closed -$41K 246
2014
Q3
$41K Buy
+694
New +$38.7K 0.13% 59
2013
Q3
Sell
-1,234
Closed -$57K 419
2013
Q2
$57K Buy
+1,234
New +$55.3K 0.07% 93

Other funds holding THC

Pathstone Family Office's THC Position: Q3 2023 in Review

Pathstone Family Office increased its Tenet Healthcare (THC) stake by 90% in Q3 2023, buying an estimated $155K and bringing the position to 4,374 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #1337.

Pathstone Family Office first reported a position in THC in Q2 2013 and has held it in 9 quarters since. The position peaked at $376K in Q1 2022. 408 funds tracked by Wall St. Rank hold THC as of Q3 2023.

  • Pathstone Family Office held 4,374 shares of Tenet Healthcare worth $288K as of Q3 2023.
  • Pathstone Family Office bought 2,076 Tenet Healthcare shares in Q3 2023, an estimated $155K.
  • Tenet Healthcare made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1337 holding.
  • Pathstone Family Office first reported a position in Tenet Healthcare in Q2 2013 and has held it in 9 quarters since.
  • Pathstone Family Office's Tenet Healthcare position peaked at $376K in Q1 2022.
  • 408 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.